Description
The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription Drug List (PDL) for human and veterinary use.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19) | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19) | HTML | Open resource |